Octavio Marquez - 19 Jan 2024 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role
President and CEO, Director
Signature
/s/ Elizabeth C. Radigan, attorney-in-fact for Octavio Marquez
Issuer symbol
DBD
Transactions as of
19 Jan 2024
Transactions value $
$0
Form type
4
Filing time
23 Jan 2024, 16:44:51
Previous filing
01 Feb 2024
Next filing
08 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBD Common Stock Award $0 +50.1K +2385.14% $0.00 52.2K 19 Jan 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBD Employee Stock Option (right to buy) Award $0 +250K $0.00 250K 19 Jan 2024 Common Stock 250K $30.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended; option generally vests on the fourth anniversary of January 19, 2024, and is generally exercisable in 40%, 30% and 30% tranches upon the Issuer's common stock, par value $0.01 per share, achieving 20-day trading average price hurdles of $65.00, $85.00 and $95.00, respectively, by January 19, 2028.